Beimdiek et al. obtained serum AGP concentration results very similar to those presented in this study in patients with severe and moderately severe COVID-19 (median AGP concentration in COVID-19: 167 mg/dL, compared to a median of 68.9 mg/dL in the control group) [15]. The gene discussed is ATP5MK; the disease is COVID-19.